Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation

Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation

Objectives To examine the prognostic value of preoperative alfa-fetoprotein (AFP) density and other clinical factors in patients undergoing percutaneous radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC).Methods From January 2010 to December 2018, a total of 543 patients undergoing RFA...

Full description

Bibliographic Details
Main Authors:	Bo-Wen Zhuang, Wei Li, Bin Qiao, Nan Zhang, Man-Xia Lin, Wei Wang, Ming Kuang, Ming-De Lu, Xiao-Yan Xie, Xiao-Hua Xie
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Series:	International Journal of Hyperthermia
Subjects:	Hepatocellular carcinoma alfa-fetoprotein radiofrequency ablation overall survival progression-free survival
Online Access:	https://www.tandfonline.com/doi/10.1080/02656736.2022.2116491

Similar Items

Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma
by: Ming Liu, et al.
Published: (2023-03-01)

Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm
by: Lei Zheng, et al.
Published: (2020-03-01)

Laparoscopic hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
by: Li X, et al.
Published: (2019-06-01)

Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study
by: Zhenhua Lu, et al.
Published: (2021-06-01)

Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Hepatectomy for Hepatocellular Carcinoma: A Meta-Analysis
by: Yuan Dan, et al.
Published: (2022-07-01)

Irregular vascular pattern by contrast‐enhanced ultrasonography and high serum Lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early‐stage hepatocellular carcinoma
by: Hitomi Takada, et al.
Published: (2016-11-01)

Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After Curative Resection: A 10-Year Single-Center Comparative Study
by: Xin Zheng, et al.
Published: (2021-09-01)

Efficacy of radiofrequency ablation and microwave ablation in the treatment of thoracic cancer: A systematic review and meta‐analysis
by: Yuan‐dong Sun, et al.
Published: (2019-03-01)

Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study
by: Liangliang Yan, et al.
Published: (2021-04-01)

Preoperative Albumin–Bilirubin Grade With Prognostic Nutritional Index Predicts the Outcome of Patients With Early-Stage Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation
by: Jingying Pan, et al.
Published: (2020-11-01)

Radiofrequency ablation for pediatric recurrent hepatocellular carcinoma: a single-center experience
by: Haiyi Long, et al.
Published: (2023-12-01)

Phase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver Metastases
by: Xiaodong Li, et al.
Published: (2016-11-01)

A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Jingzhi Huang, et al.
Published: (2023-12-01)

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
by: Rui Chen, et al.
Published: (2023-02-01)

Liver resection, radiofrequency ablation, and radiofrequency ablation combined with transcatheter arterial chemoembolization for very-early- and early-stage hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis for comparison of efficacy
by: Yunlong Zhang, et al.
Published: (2022-10-01)

Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastasis from pancreatic adenocarcinoma
by: Yu-qing Du, et al.
Published: (2022-12-01)

Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy
by: Feng Zhang, et al.
Published: (2021-01-01)

Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors
by: Li Liu, et al.
Published: (2024-12-01)

Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation
by: Lariza Marie Canseco, et al.
Published: (2023-09-01)

TACE-assisted multi-image guided radiofrequency ablation for the treatment of single hepatocellular carcinoma ≤ 5 cm: a retrospective study
by: Yong Xie, et al.
Published: (2024-04-01)

Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience
by: Baoxian Liu, et al.
Published: (2020-01-01)

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial
by: M. S. Walma, et al.
Published: (2021-04-01)

Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma
by: Jungnam Lee, et al.
Published: (2022-04-01)

Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study
by: Wendell Espinosa, et al.
Published: (2018-03-01)

Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
by: Lei Wang, et al.
Published: (2020-01-01)

Comparison of stereotactic body radiation therapy with hepatic resection and radiofrequency ablation as initial treatment in patients with early-stage hepatocellular carcinoma
by: Zi-liang Yang, et al.
Published: (2022-11-01)

Efficacy and safety of laparoscopic liver resection versus radiofrequency ablation in patients with early and small hepatocellular carcinoma: an updated meta-analysis and meta-regression of observational studies
by: Mahmoud Shaaban Abdelgalil, et al.
Published: (2024-02-01)

Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study
by: Guodong Wu, et al.
Published: (2023-03-01)

Multiple-Electrode Switching-Based Radiofrequency Ablation vs. Conventional Radiofrequency Ablation for Single Early-Stage Hepatocellular Carcinoma Ranging From 2 to 5 Cm
by: Guang-liang Huang, et al.
Published: (2020-07-01)

Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound
by: Weimin Zhang, et al.
Published: (2017-07-01)

Periprocedural risk factors for incomplete radiofrequency ablation of liver metastases from colorectal cancer: a single-center retrospective analysis
by: Hongjie Fan, et al.
Published: (2021-01-01)

A Real-World Comparative Study of Microwave and Radiofrequency Ablation in Treatment-Naïve and Recurrent Hepatocellular Carcinoma
by: Soon Kyu Lee, et al.
Published: (2022-01-01)

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
by: Yun Xu, et al.
Published: (2017-01-01)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
by: Min Hwan Kwak, et al.
Published: (2022-07-01)

Ductus Venosus Doppler S/D Value Adjusted Alfa Fetoprotein Levels to Decrease False Positive Rates
by: Alptekin Tosun, et al.
Published: (2016-05-01)

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Chang Gon Kim, et al.
Published: (2019-09-01)

Αlpha-fetoprotein Producing Gastric Cancer with Yolk Sac Component: Two Rare Case Reports
by: Bita Geramizadeh, et al.
Published: (2016-04-01)

Percutaneous radiofrequency ablation of renal tumours: 29-month mean follow-up results of 118 patients
by: Albertas Ulys, et al.
Published: (2014-02-01)

Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Jingjun Huang, et al.
Published: (2021-05-01)

Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis
by: Li-Jun Wang, et al.
Published: (2018-10-01)